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cough, and fever. The autopsy revealed a destroyed aortic
valve with extensive vegetations, and in the aortic arch there
were four aneurysms that had developed as complications of
endocarditis. The largest aneurysm, presenting a condition of
mycotic endarteritis, had perforated the aneurysmal sac and
caused a rupture into the pericardium.
Nowadays, most authors use the term mycotic
aneurysm in a broader sense to describe any kind of
infected aneurysm, regardless of its pathogenesis. Such
aneurysms may result from bacteremia and embolization
of infectious material, which cause superinfection of a dis-
eased and roughened atherosclerotic surface.2-6 Rarely,
bacteria may also colonize the intact vascular wall through
the vasa vasorum2,5-7; the localized suppurative process
The misleading term mycotic was introduced by William
Osler1 in 1885 as part of a description of a 30-year-old man
who was dying after a period of diarrhea, chills, headache,
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Objective: A mycotic aneurysm of the aorta and adjacent arteries is a dreadful condition, threatening life, organs, and
limbs. With regard to the aortic segment involved, repair by either in situ replacement or extra-anatomic reconstruc-
tion can be quite challenging. Even when surgery has been successful, the prognosis is described as very poor because
of the weakened health status of the patient who has developed this type of aneurysm. The aim of our study was to
find out whether any progress could be achieved in a single center over a long time period (18 years) through use of
surgical techniques and antiseptic adjuncts.
Material and Methods: From January 1983 to December 1999, a total of 2520 patients with aneurysms of the thoracic
and abdominal aorta and iliac arteries underwent surgery for aortic or iliac replacement at our institution. During that
period, 33 (1.31%) of these patients (mean age, 64.3 years) were treated for mycotic aneurysms of the lower descend-
ing and thoracoabdominal (n = 13), suprarenal (n = 4), and infrarenal (n = 10) aorta and iliac arteries (n = 6). Twenty
(61%) of these 33 patients had histories of various septic diseases; in the other 13 (39%), the etiology remained uncer-
tain. Preoperative signs of infection, such as leukocytosis and elevated C-reactive protein, were found in 79% of the
patients, and fever was apparent in 48%; 76% of the patients complained of pain. At the time of surgery, eight (24%)
mycotic aneurysms were already ruptured, and 20 (61%) had penetrated into the periaortic tissues, forming a contained
rupture. Five (15%) aneurysms were completely intact. The predominant microorganisms found in the aneurysm sac
were Staphylococcus aureus and Salmonella species. Careful debridement of all infected tissue was essential. In the
infrarenal aortic and iliac vascular bed, in situ reconstruction was performed only in cases of anticipated “low-grade”
infection. Alternative revascularization with extra-anatomic procedures (axillobifemoral or femorofemoral crossover
bypass graft) was carried out in eight of 16 cases. All four suprarenal and all 13 mycotic aneurysms of the thoracoab-
dominal aortic segment were repaired in situ. Antibiotics were administered perioperatively, and all patients were sub-
sequently treated with long-term antibiotics.
Results: In-hospital mortality was 36% (n = 12). Because of the smallness and heterogeneity of the sample, we could
not demonstrate significant evidence for any influence of aneurysm location or type of reconstruction on patients’
outcome. However, survival was clearly influenced by the status of rupture. During long-term follow-up (mean,
30 months; range, 1-139 months), 10 patients (48%) died—one (4.8%) probably as a consequence of the mycotic
aneurysm, the others for unrelated reasons. Eleven patients (52%) are alive and well today, with no signs of per-
sistent or recurrent infection.
Conclusions: A mycotic aneurysm of the aortic iliac region remains a life-threatening condition, especially if the
aneurysm has already ruptured by the time of surgery. Although the content of the aneurysm sac is considered septic,
as was proved by positive cultures in 85% of our patients, in situ reconstruction is feasible and, surprisingly, was not
more closely related to higher morbidity and mortality in our series than ligation and extra-anatomic reconstruction,
although most of the aneurysms repaired in situ were located at the suprarenal and thoracoabdominal aorta. We assume
that our operative mortality rate of 36%, which relates to a rupture rate of 85%, could be substantially lowered if the
diagnosis of mycotic aneurysm were established before rupture. (J Vasc Surg 2001;33:106-13.)
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weakens the arterial wall and allows formation of an
aneurysm. Alternatively, an extravascular infectious focus,
such as vertebral osteomyelitis, may penetrate directly or
through the lymphatic tissue into an adjacent vascular
structure, leading to necrosis, bleeding, and formation of
a pseudoaneurysm.7-9
A painful, rapidly growing aneurysm, often already
ruptured at the time of operation, together with a history
of fever, leukocytosis, and positive blood cultures,6 is very
suggestive of a mycotic aneurysm and should not be con-
fused with an asymptomatic aneurysm, in which bacteria
are found accidentally.10 It has been reported that cultures
of the abdominal aortic aneurysm content, routinely taken
during surgery, were positive in up to 15% of cases, and
even in the aortic wall itself, antigens of such organisms as
Chlamydia pneumoniae could be demonstrated by means
of immunohistochemistry.11-13 However, in the absence
of any clinical signs of infection, these findings do not jus-
tify a diagnosis of mycotic aneurysm.
This report is concerned with a review of the senior
author’s (W.S.) experience in the surgical treatment of 33
patients with mycotic aneurysms of the descending aorta
and the iliac region.
PATIENTS AND METHODS
From January 4, 1983, to December 12, 1999, we
treated 33 patients with a mycotic aortic or iliac aneurysm
at our institution. Analysis of the group was prospective in
13 cases and retrospective in 20 cases. The group consisted
of eight women and 25 men with a mean age of 64.3 years
(range, 48.4-77.3 years). The diagnosis of mycotic
aneurysm was accepted if (1) the aneurysm was associated
with a positive culture from the aneurysmal wall, its con-
tent, or the surrounding tissue and (2) the patient dis-
played signs of an associated infection. Aneurysms with
sterile cultures were considered “mycotic” only if (1) they
intraoperatively displayed the typical aspect of an eccentric
and perforated or penetrated aneurysm, (2) the patient had
signs of infection, and (3) the patient had been treated with
antibiotics before surgery. All medical and surgical records
and imaging studies were reviewed.
Follow-up after a mean of 30 months (range, 1-139
months) consisted of abdominal and/or thoracic computed
tomography (CT) and laboratory examinations, such as
blood count and C-reactive protein (CRP). Information
about the patients who had died in the meantime was drawn
from autopsy reports, official death certificates, and inter-
views with the patients’ physicians or relatives.
Etiology. Etiology was unknown in 13 (39%) patients.
Fourteen (42%) patients had histories of various septic dis-
eases, including spondylodiskitis (n = 2), previous colec-
tomy with anastomosis dehiscence and peritonitis (n = 1),
esophagus perforation with mediastinitis (n = 1), pneu-
monia (n = 1), previous intramuscular injection causing
various abcesses in different sites (n = 1), and pancreatitis
(n = 1). One patient had had an infrarenal mycotic
aneurysm and had been treated by in situ reconstruction
in another hospital; 8 months later, he had a new mycotic
aortic aneurysm at the thoracoabdominal transition zone
without infection of the prosthesis. Three patients had
undergone previous aortoarteriography, two patients had
had a previous autogeneous revascularization in another
anatomic region, and one patient had been nephrec-
tomized within the past 6 months. Six patients (18%) had
presented with Salmonella species in their preoperative
blood cultures or intraoperative specimens; in these cases,
the modus of the infection remained unclear (Table I).
Analysis of the associated conditions revealed that each of
five patients (15%) had malignant disease (leukemia or
lymphoma, n = 3; colon cancer, n = 1; prostate cancer, n
= 1), and two others were taking long-term corticoid
medication because of rheumatism (n = 2), which indi-
cated depressed immunocompetence. Eight patients had
diabetes mellitus.
Symptoms and clinical and radiologic findings.
Twenty-six (79%) patients demonstrated preoperative
signs of infection, such as leukocytosis and elevated CRP,
whereas only 16 patients (48%) had elevated temperature.
In each of eight patients (24%), a preoperative blood cul-
ture was taken and found to be positive. Interestingly,
most of the aneurysms were symptomatic; 25 patients
(76%) complained of severe back, abdominal, or thoracic
pain, depending on the location of the aneurysm. In addi-
tion, four patients with mycotic thoracoabdominal aortic
aneurysm had respiratory insufficiency, and two of these
had to be intubated and ventilated before surgery. In three
patients, kidney function deteriorated preoperatively (one
patient required hemodialysis). One patient had acute
right heart failure because of a mycotic fistula between the
aorta and the inferior vena cava.
Because of hemorrhagic (n = 3) or septic (n = 1)
shock, four patients underwent surgery immediately after
admission; there had been no previous investigations in
these cases. CT scanning was performed in 27 cases and
magnetic resonance imaging (MRI) in two cases. Signs of
rupture or penetration were seen in CT or MRI scans in
24 cases, whereas each of six scans revealed a rapidly
enlarging aneurysm since the previous investigation (Fig
1). Two CT scans displayed a soft tissue mass around the
aorta, and one scan displayed a fistula between the aorta
and the inferior vena cava. An eccentrically configured aor-
tic aneurysm was the only sign in one CT scan. One
angiography demonstrated a saccular aneurysm.
Bacteriology. Cultures from specimens of aneurysmal
content, the arterial wall, or the surrounding tissue were
obtained from 30 patients (Table I). In three patients,
intraoperative bacteriologic investigation was not per-
formed, but blood cultures taken before surgery had
shown Salmonella species in two cases and Staphylococcus
aureus in one case. In eight patients (24%), cultures were
negative, probably because antibiotics had been given for
some time. All eight of these patients had preoperative
signs of infection, and in three patients blood cultures
taken before surgery had shown microorganisms
(Salmonella, n = 1; S aureus, n = 1; Escherichia coli, n = 1).
Gram-positive organisms predominated, S aureus being
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the most common. Salmonella species were seen in three
intraoperative cultures and also in three blood cultures.
Only four of the intraoperative specimens yielded, in addi-
tion to Salmonella, gram-negative organisms such as E coli
and Bacteroides species. Aspergillus could be demonstrated
in one specimen. Three cultures revealed bacterial growth
of two different organisms (E coli combined with
Enterococcus and Streptococcus together with Staphylococcus
epidermidis).
Anatomic location. The mycotic aneurysms in our
material occurred in all parts of the descending aorta and
the iliac arteries (Table II). The iliac arteries were affected
in six cases and the infrarenal aorta in 10 cases. Each of four
patients had a suprarenal mycotic aneurysm and could be
treated through use of a transperitoneal approach. Each of
seven patients had a mycotic aneurysm of the thoracoab-
dominal transition zone (TAA IV) and required a thoraco-
laparotomy (Fig 2). The thoracic descending aorta alone
(TAA I) was concerned in four cases, and two other cases
were thoracoabdominal aneurysms of type II and type III
(Crawford’s classification).14
Eight (24%) of the mycotic aneurysms had already rup-
tured at time of surgery. Free rupture and shock were 
present in 3 patients with iliac aneurysms, whereas 2
infrarenal mycotic aortic aneurysms had ruptured into the
retroperitoneum, 1 infrarenal mycotic aneurysm had rup-
tured into the inferior vena cava and caused a significant
shunt, 1 thoracic aneurysm had perforated into a bronchus,
and 1 thoracic aneurysm had perforated into the lung.
Chronic- contained rupture and penetration into the
periaortic tissues were observed in 20 cases (61%). Only five
mycotic aneurysms (15%) were still intact at time of surgery
and had not perforated or penetrated (Table III).
Choice of surgical procedure. In the infrarenal aorta
and iliac arteries, revascularization was performed either by
in situ reconstruction or by extra-anatomic procedures
(Table IV). In general, the indication for extra-anatomic
revascularization was a severe infection with pus in the
aneurysmal cavity or with purulent periaortic tissue, whereas
in situ reconstruction was performed in case of low-grade
infection (pseudoaneurysm, absence of pus). However, all
suprarenal and thoracoabdominal mycotic abdominal
Table I. Bacteriology and probable etiology of mycotic aneurysm
No. of No. of 
specimens specimens
Bacteria cultured from IO specimens (n = 36) (% ) Probable etiology (n = 36)
Staphylococcus aureus 6+ (22) Aortoarteriography 2
No IO specimen, blood culture positive* 1 Intervertebral discitis 1
IO specimen negative, blood culture positive† 1 Previous vascular reconstruction 1
Intramuscular injection 1
Unknown 3
Staphylococcus epidermidis‡ 3 (8) Aortoarteriography 1
Unknown 2
Enterococcus species‡ 4 (11) Colon cancer, dehiscence, and peritonitis 1
Esophagus perforation and mediastinitis 1
Unknown 2
Streptococcus species‡ 4 (11) Previous vascular reconstruction 1
Unknown 3
Salmonella species 3+ (17) Unknown 6
No IO specimen, blood culture positive* 2
IO specimen negative, blood culture positive† 1
Escherichia coli‡ 2 (9) Colon cancer, dehiscence, and peritonitis 1
IO specimen negative, blood culture positive† 1 Unknown 2
Bacteroides species 2 (5.5) Previous nephrectomy 1
Unknown 1
Aspergillus 1 (3) Pneumonia 1
IO specimen sterile (no blood culture) 5 (14) Pancreatitis 1
No blood culture Intervertebral discitis 1
Unknown 3
IO, Intraoperative.
*In three cases, no IO culture was taken but preoperative blood cultures had revealed an organism.
†Three patients had sterile IO cultures and had shown microorganisms in blood culture.
‡In three IO specimens, two different organisms were observed.
Table II. Location of mycotic aneurysm
Location No. of patients %
Iliac artery 6 18.2
Aorta abdominal 14 42.4
Infrarenal 10
Suprarenal 4
Aorta thoracoabdominal 13 39.4
TAA I 4
TAA II 1
TAA III 1
TAA IV 7
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aneurysms were reconstructed in situ because of the difficult
anatomic region and the necessity of simultaneous revascu-
larization of intercostal, visceral, and renal arteries.
Revascularization was achieved by either axillo-
bifemoral (n = 7) or femorofemoral (n = 1) bypass graft
in eight (50%) of 16 mycotic aneurysms of the infrarenal
aortic and iliac circulation. All 17 patients with mycotic
aneurysms in suprarenal or thoracoabdominal locations
were treated in situ either with patch plasty or with tube
graft (both consisting of warp-knitted, double velour
polyester impregnated with absorbable modified
gelatin). Visceral or renal arteries had to be reimplanted
in nine patients. Rigorous debridement of all infected
tissue was carried out, and healing was supported by an
omental pedicle when this was technically possible. All
in situ replaced grafts were soaked with rifampin and
covered with gentamicin-soaked gauze. Antibiotics were
administered perioperatively and postoperatively. All
patients were given long-term treatment with specific
antibiotics according to sensitivity studies.
RESULTS
Statistical analysis. Because of the lack of power in
the sample (n = 33) and the retrospective nature of the
survey in most patients, a meaningful statistical analysis
was not possible. The multitude of factors that might
influence outcome (eg, anatomic location, surgical treat-
ment, status of rupture, and bacteriology) would necessi-
tate a much greater number of cases than were available
for this series, which is already one of the largest published
to date. For demonstrating late survival results, a cumula-
tive Kaplan-Meier analysis was used.
Early results. Of the 2520 patients treated at our
institution for thoracic and abdominal aortic and iliac
aneurysms during the past 18 years, 33 (1.31%) had
mycotic aneurysms. In-hospital mortality for this condi-
tion was 36% (n = 12; Table IV). Twelve patients died a
mean of 12.4 days (range, 0-40 days) after surgery; one
patient died of cardiac failure during surgery. One patient
died 9 days after surgery for cardiac reasons; 1 patient suc-
cumbed to hypovolemic shock; 2 patients died because of
respiratory failure, 4 because of sepsis, and 3 because of
multiorgan failure due to sepsis.
Despite the statistical shortcomings of this series,
some of the results are intuitively convincing. Survival was
clearly dependent on the state of rupture (Table III). All 5
patients with intact mycotic aneurysms survived the peri-
operative period, whereas 5 (63%) of 8 patients with
aneurysm rupture and 7 (35%) of 20 patients with con-
tained rupture forming a pseudoaneurysm died in the hos-
pital. In our small sample, outcome did not depend on the
anatomic location of the mycotic aneurysm; mortality
ranged from 33% (iliac aneurysms) to 38% (thoracoab-
dominal aneurysms; Table IV). The influence of type of
surgical management on early outcome is not quite clear.
Four (50%) of eight of the extra-anatomically recon-
structed patients died; this compared with eight (32%) of
the 25 patients with in situ revascularization.
Each of three patients with a type IV mycotic thora-
coabdominal aneurysm had a mild paraparesis that resolved
Fig 1. Progression of mycotic suprarenal aortic aneurysm during 1 month.
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within 1 year. One patient had thoracic bleeding, which
was treated successfully. One patient with salmonellosis had
a psoas muscle abscess in addition to his mycotic infrarenal
aortic aneurysm; he was reconstructed in situ. Post-
operative CT scans revealed that the psoas muscle abscess
persisted without any signs of prosthetic infection. The
abscess was successfully drained through use of CT-guided
methods and disappeared within 1 week. CT scans taken 1
month after removal of the drain did not show any signs of
abscess recurrence. Two other patients displayed some liq-
uid around the prosthesis after in situ reconstruction of the
mycotic aneurysm. Interventional drain lavage and micro-
biologic analysis revealed that the periprosthetic liquid was
Fig 2. Mycotic aortic aneurysm of thoracoabdominal region.
Table III. Number of perioperative deaths in 
relation to status of perforation
Status of No. of No. of perioperative
perforation patients (%) deaths (%)
Rupture 8 (24) 5 (63)
Free 3 2
Into retroperitoneum 2 2
Into other organs 3 1
Contained rupture
(pseudoaneurysmal) 20 (61) 7 (35)
Intact 5 (15) 0 (0)
Totals 33 (100) 12 (36)
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sterile, and CT scans taken 6 weeks after removal of the
drain showed no evidence of prosthetic infection.
Late results. Complete follow-up of all 21 (100%) sur-
viving patients at a mean of 30 months (range, 1-139
months) was achieved. At a follow-up of 47 months (range,
2-139 months), 10 patients (48%) had died. One patient
with a history of colectomy for tumor, anastomotic dehis-
cence, peritonitis, and mycotic iliac aneurysm had under-
gone in situ reconstruction and died 2 months later; autopsy
revealed a persistent peritonitis and liver metastasis. The
other nine patients died of unrelated causes, such as cardiac
problems (n = 4), cancer (n = 2), stroke (n = 1), subarach-
noidal bleeding (n = 1), and gastrointestinal bleeding result-
ing from pancreatitis (n = 1). For the cumulative survival
rate, a Kaplan-Meier survival analysis was done (Fig 3).
Follow-up of the 11 survivors was achieved up to a
mean of 15 months (range, 1-67 months). One patient in
poor health who had required intubation and dialysis
before surgery had a type IV mycotic thoracoabdominal
aneurysm and was reconstructed urgently with a Dacron
patch. CT scanning done postoperatively and 12 months
later showed a second, probably mycotic aneurysm distal
to the patch in the infrarenal region. Reoperation, this
time through use of the transperitoneal approach, was per-
formed successfully 15 months after the first operation.
The aneurysm had penetrated into the right retroperi-
toneum and had not been detected during the first recon-
struction through the thoracoabdominal approach. The
other 10 patients are well, without any signs of infection.
DISCUSSION
Although mycotic aneurysms have been reported in all
age groups, including newborns, the typical patient is
elderly and atherosclerotic.6,15,16 In our study, the mean
age of the patients, 64 years, was comparable to that for all
of the other patients who underwent aneurysm surgery at
our institution.17
Over the past 30 years, there has been a change in the
etiology of mycotic aneurysms.9 Since the introduction of
antibiotics, endocarditis as a source of bacteremia has
become rare, and several risk factors for mycotic
aneurysm, especially in older patients, are currently more
common. As seen in our study, these include diagnostic or
therapeutic arterial catheterization, previous operations in
distant sites, and depressed immunocompetence sec-
ondary to (1) chronic or neoplastic diseases and (2)
administration of corticoid or cytotoxic agents.18,19 In
accord with the findings in several other reports,3,4,9 S
aureus and Salmonella species were the most common
organisms cultured from our intraoperative specimens.
Microorganisms often lodge in the intimal layer of a dis-
eased vascular segment. A predilection for congenitally
abnormal (eg, coarctation) or atherosclerotic segments has
been described.4,5 We could not recognize any predilec-
tion zone in the aortoiliac vascular bed, but as previously
described by Chan et al,4 mycotic aneurysms in the vis-
ceral segment of the thoracolumbar aorta were common,
perhaps because the atherosclerotic destruction can be
very prominent in this region.
In comparison with noninfected aortic aneurysms,
mycotic aneurysms are “symptomatic,” and 76% of our
patients complained of abdominal, back, or thoracic pain.
Forty-eight percent of the patients had fever, and 79% had
laboratory changes indicating infection. These findings,
together with CT signs such as a rapidly growing or newly
developed aneurysm, air in the aortic wall, a leakage of
aortic contrast material, a saccular aneurysm, or a soft tis-
sue mass surrounding the nondilatated or aneurysmal
aorta (often accompanied by a broken calcified atheroscle-
rotic aortic plaque3,5,20-22), are suggestive of an infected
aneurysm, and early operative intervention is indicated.
In the past 30 years, ever since Bennett and Cherry23
reported that infected aneurysms of the abdominal aorta
were invariably fatal, possibilities for surgical and medical
Table IV. Location of mycotic aneurysm, surgical management, and relation to perioperative mortality
In situ
All patients/ Extra-anatomic/ Tubular graft/ Patch/
No. of peri- Mortality No. of peri- Mortality No. of peri- Mortality No. of peri- Mortality
Location operative deaths (%) operative deaths (%) operative deaths (%) operative deaths (%)
Iliac artery 6/2 33 3/2 67 3/0 0 — —
Aorta: abdominal 14/5 36 5/2 40 9/3 33 — —
Infrarenal 10/5 50 5/2 40 5/3 60 — —
Suprarenal* 4/0 0 — — 4/0 0 — —
Aorta: thoracoabdominal† 13/5 38 — — 9/3 33 4/2 50
TAA IV* 7/1 14 — — 5/0 0 2/1 50
TAA III 1/0 0 — — — — 1/0 0
TAA II* 1/1 100 — — 1/1 100 — —
TAA I 4/3 75 — — 3/2 67 1/1 100
Subtotals — — — — 21/6 29 4/2 50
Totals 33/12 (36%) 8/4 (50%) 25/8 (32%)
*In nine cases, visceral and/or renal arteries had to be reimplanted.
†Crawford classification.
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treatment have improved. Nevertheless, the optimal man-
agement of infected aneurysms remains controversial. For
the infrarenal aorta and iliac arteries, ligation of the aorta
and extra-anatomic bypass graft has been considered the
standard treatment for aortic sepsis to avoid the use of
grafts in a contaminated region.23,24 Despite lifelong anti-
coagulation, however, patency rates for long axillo-
bifemoral bypass grafts are poor, and aortic stump bleeding
has been reported.3,25,26 When the mycotic process
involves the visceral aortic segment, the infected region
cannot be avoided and in situ reconstruction with reim-
plantation of visceral or renal arteries may be less hazardous
than extra-anatomic reconstruction.4,24,33-35 This maneu-
ver must be combined with an accurate debridement of all
infected tissue, and the reconstruction should be covered
with an omental flap if this is technically possible.
It is recommended that in situ replaced grafts be soaked
with rifampin,28-32 which has a considerable antistaphylo-
coccal activity and has already been shown to bind signifi-
cantly to gelatin-sealed Dacron grafts. Furthermore, the
intraoperative application of gentamicin-releasing carriers
has been reported,36 and we regularly use gentamicin-
soaked gauze to tamponade the pseudoaneurysmatic cavity.
As an alternative to tubular graft replacement, a Dacron
patch angioplasty can be performed if the lesion is well cir-
cumscribed and the adjacent aorta is not dilatated.4,24
Our applied surgical technique varied according to the
anatomic location of the mycotic aneurysm and the sever-
ity of its infection. In the infrarenal vascular bed, in situ
reconstruction was performed in cases of low-grade infec-
tion if the inflammatory process was circumscribed and
pus was absent. If a severe purulent infection was seen,
extra-anatomic bypass graft was considered, and this was
performed in one half of our infrarenal mycotic aortic and
iliac aneurysms. In the suprarenal and thoracoabdominal
region, in situ revascularization was carried out in each
patient by means of either a tube graft or a patch angio-
plasty. Because of the smallness of the sample, our study
could not detect any statistical significance as regards the
extent to which different surgical procedures influenced
patient outcome. The mortality was higher in the “extra-
anatomic revascularization” group in our sample, but
these patients probably had undergone a negative selec-
tion because of the decision to use extra-anatomic proce-
dures in cases of severe infection. Outcomes for our
patients were worse when the aneurysm had already rup-
tured or penetrated and formed a pseudoaneurysm. This
supports the hypothesis that early diagnosis and timely
operation might be the most important factors in the sur-
vival of patients with aortic sepsis.3,37 In any case of
unclear or persistent sepsis, especially in a young drug user
or an elderly patient with depressed immunocompetence
(diabetes mellitus, previous malignant disease, corticos-
teroid medication), a diagnosis of mycotic aneurysm
should be considered, and thoracoabdominal CT scans
should be performed in a timely manner.
Intensive antibiotic therapy is crucial for successful
treatment and should be started perioperatively; a broad-
Fig 3. Kaplan-Meier survival analysis.
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spectrum antibiotic should be used until culture sensitivity
reports are available and a specific antibiotic is deter-
mined.28 The required duration of antibiotic therapy is
not well established; recommendations range from 6-8
weeks to lifelong.4,9,28 In our opinion, postoperative
antibiotics should be administered for at least 3 months
and should be discontinued only when careful examina-
tion of the patient reveals no further signs of infection.
Regular controls with CT scans and control of infection
parameters, such as CRP, are necessary, because recurrent
or persistent aortic or graft infections might occur.4,10,28
In our own sample, postoperative CT scans revealed one
persistent abscess of the psoas muscle without any signs of
prosthetic infection; this was successfully treated with
interventional drainage and lavage. In postoperative CT
scans, each of two additional patients displayed a persistent
periprosthetic liquid in the former aneurysmal sac.
Diagnostic interventional drainage of the liquid was there-
fore performed; fortunately, this did not show any evi-
dence of prosthetic infection later on.
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